August 27, 2024 — How big might the semaglutide budget bomb be? The authors of a new brief report in Annals of Internal Medicine today are making a point. How threatening can we make this sound? Right up front in their title, they label their estimates as the “maximum costs of expanded Medicare coverage of semaglutide for cardiovascular risk […]
June 28, 2024 — With a bipartisan a vote of 36-4 yesterday, the House Ways and Means Committee passed an amended version of TROA – the Treat and Reduce Obesity Act. Honestly, after a decade of toiling away to educate legislators about the need for this, we need a pinch to assure ourselves it’s real. This is great news […]
June 12, 2024 — Senator Bernie Sanders doesn’t want to let this go. Novo Nordisk isn’t eager to cut its thousand-dollar list price for Ozempic. Nor is it eager to face a grilling about this in the Senate. So yesterday, Sanders announced that the Senate Health, Education, Labor, and Pensions committee will vote next Tuesday on a subpoena for […]
April 30, 2024 — Last week, the U.S. Senate launched an investigation into the high price of semaglutide, sold as Ozempic and Wegovy by Novo Nordisk. Yes, pressure on GLP-1 pricing is building and you can be confident there’s more to come. Senator Bernie Sanders chairs the Senate Committee on Health, Education, Labor, and Pensions, which is undertaking this […]
March 30, 2024 — Remember when grains were good? Judging by the nutrition red alert arising from the possibility that potatoes might be classified as a grain instead of a vegetable, maybe grains are on the naughty list now. Brave potato defenders in the U.S. Senate are rising up to keep this from happening. They want to save us […]
March 28, 2024 — A new economic analysis in JAMA Network Open brings unsurprising news: manufacturing costs for GLP-1 agonists are a tiny fraction of the price for these important medicines. This is always the case for innovative prescription drugs that must recover billions of dollars of development costs in order to be profitable. The response from policy makers […]
March 10, 2024 — For many of us, it’s just too painful to think about. But a rerun of the 2020 presidential election is coming and drug pricing is likely to be a big talking point for both of the major candidates. President Biden is talking about corporate greed while former President Trump is talking about reviving an executive […]
January 28, 2024 — In public life and unfortunately, in science and health policy, we find too often that contempt takes over from curiosity and reason. It is obvious in politics and likely to get painful this year. But it is not confined to the political realm. In nutrition and obesity research, we find that people are often ready […]
January 14, 2024 — Following in America’s footsteps, the UK applies something of a make-believe approach to dealing with obesity. With furrowed brow, policy makers acknowledge that obesity is undermining the health of the nation – not to mention the financial status of the vaunted National Health Service. The consequences of untreated obesity are multiplying so fast that it’s […]
January 12, 2024 — This is a new political fashion we hope will quickly find its place in the discards bin. Iowa Governor Kim Reynolds is declining federal summer food aid for kids saying, “An EBT card does nothing to promote nutrition at a time when childhood obesity has become an epidemic.” USDA this summer will launch a permanent […]
